PL2748605T4 - Sposoby i kompozycje do diagnozowania i prognozowania uszkodzenia nerek i niewydolności nerek - Google Patents

Sposoby i kompozycje do diagnozowania i prognozowania uszkodzenia nerek i niewydolności nerek

Info

Publication number
PL2748605T4
PL2748605T4 PL12832845T PL12832845T PL2748605T4 PL 2748605 T4 PL2748605 T4 PL 2748605T4 PL 12832845 T PL12832845 T PL 12832845T PL 12832845 T PL12832845 T PL 12832845T PL 2748605 T4 PL2748605 T4 PL 2748605T4
Authority
PL
Poland
Prior art keywords
renal
prognosis
diagnosis
compositions
methods
Prior art date
Application number
PL12832845T
Other languages
English (en)
Other versions
PL2748605T3 (pl
Inventor
Joseph Anderberg
Jeff Gray
Paul Mcpherson
Kevin Nakamura
James Patrick Kampf
Original Assignee
Astute Medical, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical, Inc. filed Critical Astute Medical, Inc.
Publication of PL2748605T4 publication Critical patent/PL2748605T4/pl
Publication of PL2748605T3 publication Critical patent/PL2748605T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
PL12832845T 2011-08-26 2012-08-24 Sposoby i kompozycje do diagnozowania i prognozowania uszkodzenia nerek i niewydolności nerek PL2748605T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161528003P 2011-08-26 2011-08-26
US201161528000P 2011-08-26 2011-08-26
EP12832845.7A EP2748605B1 (en) 2011-08-26 2012-08-24 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
PCT/US2012/052298 WO2013043310A1 (en) 2011-08-26 2012-08-24 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (2)

Publication Number Publication Date
PL2748605T4 true PL2748605T4 (pl) 2019-08-30
PL2748605T3 PL2748605T3 (pl) 2019-08-30

Family

ID=47914751

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12832845T PL2748605T3 (pl) 2011-08-26 2012-08-24 Sposoby i kompozycje do diagnozowania i prognozowania uszkodzenia nerek i niewydolności nerek

Country Status (16)

Country Link
US (2) US9459261B2 (pl)
EP (2) EP2748605B1 (pl)
JP (2) JP2014529073A (pl)
KR (1) KR20140074307A (pl)
CN (2) CN106443011A (pl)
AU (1) AU2012312907A1 (pl)
BR (1) BR112014004389A2 (pl)
CA (1) CA2846602A1 (pl)
EA (1) EA201490384A1 (pl)
ES (1) ES2721907T3 (pl)
IN (1) IN2014MN00377A (pl)
MX (1) MX346096B (pl)
PL (1) PL2748605T3 (pl)
PT (1) PT2748605T (pl)
TR (1) TR201903235T4 (pl)
WO (1) WO2013043310A1 (pl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102246035B (zh) 2008-10-21 2014-10-22 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
CN104698161A (zh) 2009-12-20 2015-06-10 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
NZ605698A (en) 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
KR20140074307A (ko) * 2011-08-26 2014-06-17 아스튜트 메디컬 인코포레이티드 신장 손상 및 신부전의 진단 및 예후진단을 위한 방법 및 조성물
EP2788759B1 (en) 2011-12-08 2019-02-20 Astute Medical, Inc. Methods and uses for diagnosis of renal injury and renal failure
CA3158996A1 (en) 2013-01-17 2014-07-24 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US11261257B2 (en) 2013-01-28 2022-03-01 Diasorin S.P.A. Methods for detecting 1,25-dihydroxyvitamin D and related antibodies
PL2759550T3 (pl) 2013-01-28 2019-01-31 Diasorin S.P.A. Sposób i zestaw do wykrywania 1,25-dihydroksywitaminy D i powiązane przeciwciała
US10983136B2 (en) * 2013-01-28 2021-04-20 Diasorin S.P.A. Use of 1,25-dihydroxyvitamin D values in ratio with PTH as a prognostic biomarker
CN110007084B (zh) 2013-12-03 2022-11-18 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
PT3210018T (pt) * 2014-10-20 2021-10-04 Astute Medical Inc Métodos e composições para o diagnóstico e prognóstico de lesão renal e insuficiência renal
WO2016113719A1 (en) * 2015-01-18 2016-07-21 Diasorin S.P.A. Use of 1,25-dihydroxyvitamin d values in ratio with pth as a prognostic biomarker
EP3281011A4 (en) 2015-04-09 2018-11-21 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN105466984B (zh) * 2016-01-14 2018-12-28 郑以山 用于肾脏非显性损伤的预警装置及其使用方法
US11243217B2 (en) 2016-06-06 2022-02-08 Astute Medical, Inc. Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
EP3568695A4 (en) 2017-01-12 2020-12-16 Astute Medical, Inc. METHODS AND COMPOSITIONS FOR THE EVALUATION AND TREATMENT OF KIDNEY INJURY AND RENAL FAILURE BASED ON A MEASUREMENT OF LIGAND CHEMIOKINE ON C-C 14
EP3577458A4 (en) 2017-02-06 2021-04-07 Astute Medical, Inc. METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PREDICTION OF RENAL LESION AND RENAL INSUFFICIENCY
US11718682B2 (en) 2017-04-05 2023-08-08 Astute Medical, Inc. Assays for TIMP2 having improved performance in biological samples
KR20210019459A (ko) 2018-05-24 2021-02-22 레니버스 테라퓨틱스, 인크. 신장 손상 및 신부전 위험이 있는 환자를 치료하는 방법
CN109251956A (zh) * 2018-09-18 2019-01-22 青岛大学 糖尿病大鼠胰岛内MyD88 mRNA表达及黄芪的调节作用
US20220178946A1 (en) * 2018-11-02 2022-06-09 Prevencio, Inc. Prognostic and diagnostic methods for risk of acute kidney injury
CN114113575B (zh) * 2020-08-28 2023-06-02 菲鹏生物股份有限公司 标记复合物及其制备方法与应用
CN116434960B (zh) * 2023-06-13 2023-10-13 中国人民解放军总医院 一种心源性休克临床决策支持系统、设备及可存储介质

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
JPH05504841A (ja) 1990-09-14 1993-07-22 バイオサイト・ダイアグノスティックス・インコーポレイテッド リガンドレセプター及びリガンドのコンプレックスに対する抗体及びリガンド―レセプターアッセーでのそれらの用途
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
ATE177841T1 (de) 1991-04-10 1999-04-15 Biosite Diagnostics Inc ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung
CA2107899A1 (en) 1991-04-10 1992-10-11 Gunars Edwin Valkirs Novel conjugates and assays for simultaneous detection of multiple ligands
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
DE602004022150D1 (de) 2003-03-27 2009-09-03 Childrens Hosp Medical Center Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung
CN1791797A (zh) * 2003-03-27 2006-06-21 儿童医院医疗中心 用于检测肾小管细胞损伤的早发的方法和试剂盒
US7560244B2 (en) * 2003-06-04 2009-07-14 Joslin Diabetes Center, Inc. Method of evaluating a subject for risk or predisposition of reduced renal function over time
US20050272101A1 (en) 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
US20060003345A1 (en) * 2004-06-30 2006-01-05 Pfizer Inc RNA bioassay
CN101557825A (zh) * 2005-08-19 2009-10-14 森托科尔公司 抗蛋白酶解的抗体制剂
WO2007144781A2 (en) * 2006-04-21 2007-12-21 Diagnotech Pty. Ltd. Diagnostic methods and kits utilizing antibodies for metalloproteases
ES2532220T3 (es) * 2007-03-26 2015-03-25 Novartis Ag Biomarcadores de seguridad renal predictiva y señales de biomarcadores para monitorizar la función renal
PL2215481T5 (pl) * 2007-11-15 2017-10-31 Bioporto Diagnostics As Zastosowanie diagnostyczne indywidualnych postaci cząsteczkowych biomarkera
WO2009107384A1 (ja) * 2008-02-29 2009-09-03 国立大学法人名古屋大学 急性腎障害及び予後推定用バイオマーカー並びにその用途
MX341926B (es) * 2008-08-28 2016-09-07 Astute Medical Inc Metodos y composiciones para la diagnosis y prognosis de daño renal y falla renal.
EP2813848A3 (en) * 2008-08-29 2015-03-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102246035B (zh) * 2008-10-21 2014-10-22 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物
WO2010054389A1 (en) * 2008-11-10 2010-05-14 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US9229010B2 (en) * 2009-02-06 2016-01-05 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20120129265A1 (en) * 2009-06-02 2012-05-24 Biocrates Life Sciences Ag New biomarkers for assessing kidney diseases
CA2770393A1 (en) * 2009-08-07 2011-02-10 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP3299821A1 (en) * 2009-09-18 2018-03-28 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX2009012633A (es) 2009-11-23 2011-05-24 Univ Mexico Nacional Autonoma Metodo de diagnostico para detectar la lesion renal aguda a traves del uso de la proteina de choque termico de 72 kda como un biomarcador sensible.
CN104698161A (zh) * 2009-12-20 2015-06-10 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
NZ602056A (en) * 2010-02-26 2014-11-28 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
KR20140074307A (ko) * 2011-08-26 2014-06-17 아스튜트 메디컬 인코포레이티드 신장 손상 및 신부전의 진단 및 예후진단을 위한 방법 및 조성물

Also Published As

Publication number Publication date
MX2014002146A (es) 2014-08-21
US20170016917A1 (en) 2017-01-19
US9459261B2 (en) 2016-10-04
KR20140074307A (ko) 2014-06-17
CN103874923B (zh) 2016-09-14
US9784750B2 (en) 2017-10-10
BR112014004389A2 (pt) 2017-03-28
ES2721907T3 (es) 2019-08-06
US20140213477A1 (en) 2014-07-31
EP3489690A1 (en) 2019-05-29
CN106443011A (zh) 2017-02-22
JP2017032586A (ja) 2017-02-09
NZ706242A (en) 2016-07-29
CN103874923A (zh) 2014-06-18
CA2846602A1 (en) 2013-03-28
JP2014529073A (ja) 2014-10-30
EA201490384A1 (ru) 2014-08-29
EP2748605B1 (en) 2018-12-05
TR201903235T4 (tr) 2019-03-21
MX346096B (es) 2017-03-07
PT2748605T (pt) 2019-05-03
AU2012312907A1 (en) 2014-03-13
PL2748605T3 (pl) 2019-08-30
NZ621716A (en) 2016-04-29
EP2748605A4 (en) 2015-12-02
WO2013043310A1 (en) 2013-03-28
EP2748605A1 (en) 2014-07-02
IN2014MN00377A (pl) 2015-06-19

Similar Documents

Publication Publication Date Title
HK1212764A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
EP2748605A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
EP2539712A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
EP2788759A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING KIDNEY INJURY AND RENAL FAILURE
EP2513649A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
EP2480882A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL LESIONS AND FAILURES
HK1167455A1 (zh) 用於腎損傷和腎衰竭的診斷及預後方法和組合物
EP2470905A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
HK1212770A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
EP2721404A4 (en) DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
HK1170955A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
HK1162617A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1186248A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
EP2729803A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE
HK1167888A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2496942A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
HK1174367A1 (zh) 用於腎損傷和腎衰竭的診斷及預後的方法和組合物
EP2661626A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
EP2462446A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
EP2783213A4 (en) METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
HK1167889A1 (zh) 用於腎損傷和腎衰竭的診斷及預後方法和組合物
EP2585825A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE
EP2531621A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
HK1204339A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
HK1207155A1 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure